Wondering about the JNJ and ACHN HCV collaboration.
Dew, since you follow this space a bunch more that I do, I wonder what your take is on the value of this collaboration? Any value at all? Are they still in the triple therapy game with all that has gone on lately?
I am looking into the Factor D program along with back up compounds ACHN has in waiting.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.